Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multicenter, Randomized, Double-Blind, Multiple-Dose, Placebo Controlled Clinical Trial of Two Doses of PP-01 for the Mitigation of Cannabis Withdrawal Symptoms

NCT05494437 is registered in ClinicalTrials.gov with PleoPharma, Inc. as lead sponsor.

NCT NCT05494437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05494437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multicenter, Randomized, Double-Blind, Multiple-Dose, Placebo Controlled Clinical Trial of Two Doses of PP-01 for the Mitigation of Cannabis Withdrawal Symptoms
Lead sponsor
PleoPharma, Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 27, 2022
Completion date
August 21, 2023
Enrollment
234 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis withdrawal